Friday, July 10, 2026

pharma · Myelofibrosis · Myelodysplastic syndromes (MDS)

Geron Netherlands

Geron Netherlands trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
3
Drugs
2
Patents
0
Intelligence · Clinical Trials

Geron Netherlands clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Geron Netherlands programs — each row shows trial ID, program name, phase, status, and indication.

Geron Netherlands trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Geron Netherlands.

  1. GRN163LMYF3001 — Phase 3

    Clinical update
  2. 63935937MDS3001 — Phase 3

    Clinical update
  3. Imetelstat — Phase 3

    Clinical update

Trial registry

3 studies